课题基金 / 基金详情

Patient Oriented Studies of Vitamin D in Chronic Kidney Disease

Patient Oriented Studies of Vitamin D in Chronic Kidney Disease
维生素 D 在慢性肾脏病中的以患者为导向的研究
批准号:
9026599
负责人:
RAVI THADHANI
金额:
$10.92万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-15 至 2017-03-31
关键词:
AddressBackBenefits and RisksBiologicalBiological MarkersBiologyBlood specimenBone DiseasesCanadaCardiacCardiac MyocytesCardiovascular DiseasesCause of DeathChronicChronic Kidney FailureClinical ResearchData SetDiabetes MellitusDialysis patientsDialysis procedureDiseaseDisease ProgressionDoseEducational process of instructingEnd stage renal failureErgocalciferolsEscherichia coliFundingFunding AgencyGene ExpressionGenerationsGoalsGrantHealthHeart HypertrophyHemodialysisHormonesHospitalizationHypercalcemiaImmune responseIndividualIndustryInfectionInflammation MediatorsInflammatoryInstitutesInterventionKidney FailureLaboratoriesLeadLeft Ventricular HypertrophyLeft Ventricular MassLinkMeasuresMediatingMentorsMentorshipMetabolismMid-Career Clinical Scientist Award (K24)Molecular ProfilingMorbidity - disease rateNational Institute of Diabetes and Digestive and Kidney DiseasesNephrologyNew EnglandNutritionalPatientsPlacebosPlasmaPopulationPopulation CharacteristicsPublic HealthQualifyingRegimenResearchResearch PersonnelRisk FactorsSafetyScientistSingle Nucleotide PolymorphismSliceStagingStudentsSupplementationTestingTimeToxic effectTrainingUnited States National Institutes of HealthVitamin DVitamin D AnalogVitamin D DeficiencyVitamin D supplementationVitamin D3 ReceptorVitaminsbasecapsulecardiovascular disorder riskcardiovascular infectioncardiovascular visualizationcareercathelicidinclinically relevantcohortcoronary artery calcificationcytokinefibroblast growth factor 23follow-upimprovedindexinginorganic phosphatemacrophagemortalityparicalcitolpatient orientedpatient oriented researchpersonalized diagnosticsprogramsprospectiverandomized trialresponseskillstranslational studytreatment durationtreatment response

项目摘要

项目成果

RAVI THADHANI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Vitamin D deficiency is highly prevalent in patients with advanced chronic kidney disease (CKD). Cardiovascular disease (CVD) and infection are the top causes of morbidity and mortality in CKD and end- stage renal disease (ESRD). Evidence generated by the candidate's (Ravi Thadhani, MD, MPH) laboratory has linked CVD progression and altered immune response to inadequate vitamin D levels in CKD/ESRD. Under Dr. Thadhani's direction, a comprehensive patient-oriented research program seeks to investigate the relationship between vitamin D biology and supplementation strategies in terms of mechanistic and clinically relevant endpoints. This application describes three unique aims in three studies (each backed by separate funding sources) that will be pursued by the candidate and his trainees: (1) in DIVINE - an NIH sponsored trial of nutritional vitamin D - his team will determine whether nutritional vitamin D deficiency in ESRD patients leads to altered macrophage function and ex-vivo response to infection; (2) in PRIMO - an industry sponsored trial of active vitamin D and left ventricular hypertrophy [LVH], diastolic function, and cardiac hospitalization in patients with stage 3/4 CKD - his team will determine if baseline levels of 25-hydroxy vitamin D (25D) and fibroblast growth factor-23 (FGF-23) are linked to progression or lack of regression of LVH; and (3) in LUCID - a prospective cohort of incident ESRD subjects supported by the Canadian Institutes of Health - his team will examine whether active vitamin D leads to excess coronary artery calcification. By supporting the candidate's request for this K24 award, important patient-oriented questions will be addressed. Moreover, Dr. Thadhani, with an exemplary record of mentorship, teaching and research, will be afforded the necessary protected time to mentor individuals who comprise a new generation of clinical research fellows and students in Nephrology.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1159/000348806
发表时间: 2013
期刊: American journal of nephrology
影响因子: 4.2
作者: [Nigwekar SU, Bhan I, Turchin A, Skentzos SC, Hajhosseiny R, Steele D, Nazarian RM, Wenger J, Parikh S, Karumanchi A, Thadhani R]
通讯作者: Thadhani R
Fibroblast growth factor-23 and outcomes: new answers, new questions.
成纤维细胞生长因子 23 和结果:新答案,新问题。
DOI: 10.1681/asn.2013020169
发表时间: 2013
期刊: Journal of the American Society of Nephrology : JASN
影响因子: --
作者: [Bhan,Ishir, Thadhani,Ravi]
通讯作者: Thadhani,Ravi
DOI: 10.1053/j.ajkd.2015.01.034
发表时间: 2015-07
期刊: American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子: --
作者: [Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI]
通讯作者: Thadhani RI
Reply to "The role of fibroblast growth factor-23 in left atrial volume".
回复“成纤维细胞生长因子23对左心房容积的作用”。
DOI: 10.1016/j.ahj.2013.02.023
发表时间: 2013
期刊: American heart journal
影响因子: 4.8
作者: [Tamez,Hector, Andress,Dennis, Solomon,ScottD, Thadhani,Ravi]
通讯作者: Thadhani,Ravi
23
    Support of the Emory National Primate Research Center
    • 批准号:
      10844283
    • 项目类别:
    • 资助金额:
      $16.99万
    • 财政年份:
      2023
    • 负责人:
      RAVI THADHANI
    • 依托单位:
    PDE5i with Tadalafil Changes the Extent of Renal Damage (PITCH_ER)
    • 批准号:
      8606587
    • 项目类别:
    • 资助金额:
      $41.26万
    • 财政年份:
      2013
    • 负责人:
      RAVI THADHANI
    • 依托单位:
    Bioavailable Vitamin D Redefines Vitamin D Deficiency
    • 批准号:
      8331000
    • 项目类别:
    • 资助金额:
      $39.4万
    • 财政年份:
      2012
    • 负责人:
      RAVI THADHANI
    • 依托单位:
    Impact of vitamin D supplementation on cardiac structure and function
    • 批准号:
      8268146
    • 项目类别:
    • 资助金额:
      $30.7万
    • 财政年份:
      2012
    • 负责人:
      RAVI THADHANI
    • 依托单位:
    国内基金
    海外基金
    患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
    • 批准号:
      2026JJ81464
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      叶婷
    • 依托单位:
    基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
    • 批准号:
      2024KP61
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      余丹
    • 依托单位:
    基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
    • 批准号:
      51307073
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2013
    • 负责人:
      郭兴龙
    • 依托单位: